New enzymes and protein engineering have advanced biocatalysis processing toward commercial acceptance. Technology and economic roadblocks must be overcome for the process to be widely embraced by pharma.
Mark Muldowney
Advertisement
Mark Muldowney is head of technology at Sterling Pharma Solutions.
Articles by Mark Muldowney
Advertisement
Latest Updated Articles
Seeking Economies of Scale for BiocatalysisPublished: October 15th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AAPS PharmSci 360 2025: Trends in Bioanalysis
2
PharmTech Weekly News Roundup – Week of November 3, 2025
3
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
4
How AI, Machine Learning, and Large Language Models Enhance Bioanalysis
5
